2004

This article provides insight from experts such as Mark Bard, President of Manhattan Research and David Kibbe, M.D., Director, Healthcare Information Technology, American Academy of Family Physicians (AAFP), on the impact of new technologies at the point of care on pharmaceutical sales and marketing.

This article summarizes different aspects of this latest innovation in portability and performance and how they could be used to increase sales force effectiveness in both the primary care and hospital-based environments.

Richard B. Vanderveer, Ph.D., CEO of the global pharmaceutical marketing and research firm V2 GfK, presents strategies for enhanced physician targeting and segmentation.

The California legislature recently passed SB 1765 (aka, 'fair drug marketing bill'), which requires pharma companies to comply with PhRMA and OIG Guidelines. this article summarizes the provisions of this bill, which is currently awaiting signature by Governor Schwarzenegger.

This article summarizes the results of a recent Pharma Marketing News Survey on this topic.

Vioxx Withdrawal and the "Me-Too Drug Domino Effect" OpEd by John Mack Merck's "voluntary" withdrawal of Vioxx...

Several drug re-importation bills are currently being considered in Congress.

Women account for more than half of the population in the United States and it makes absolute sense to market to women where, when, and how they choose.

Multicultural communications can be a powerful addition to the armamentarium of the healthcare marketer.

This article compares pharmaceutical prices paid by governments in the United States and Canada.